Dana-Farber's new advertising campaign: "What we do here, changes lives everywhere" - Dana-Farber Cancer Institute

Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.

What we do here changes lives everywhere.

At Dana-Farber Cancer Institute, we view cancer research through a special lens—one that changes the medical landscape and brings hope to cancer patients everywhere. It started more than 70 years ago when Dr. Sidney Farber pioneered chemotherapy. It continues today with Dr. Gordon Freeman’s pivotal discovery of PD-L1, a protein that conceals cancer and, when blocked, enables the immune system to attack cancer. This discovery has transformed immunotherapy into a revolutionary way of treating cancer worldwide. Through our blend of innovative science and exceptional patient care, we will continue setting the standard for lifesaving cancer research well into the future.

Dana-Farber’s discoveries have advanced the world’s medical understanding for 72 years. This is our passion.

Immune Checkpoint Inhibitors Show Promise Against a Wide Variety of Cancers Immune checkpoint inhibitors are producing striking results in some cancers.

Learn more >

What is PD-1 and Immunotherapy? Many cancer cells wear proteins called PD-L1 to stay hidden. We’ve lifted their disguise and set the immune system on them.

Learn more >

William Kaelin, MD, Wins 2019 Nobel Prize in Physiology or Medicine Kaelin’s key molecular findings could lead to new therapeutics for cancer, cardiovascular disease, anemia, and macular degeneration.

Learn more >

IntelliSpace Precision Medicine Oncology Multi-Disciplinary Tumor Board

Dana-Farber’s Clinical Pathways & Philips IntelliSpace Precision Medicine Oncologists are matching specific therapies and trials to patient characteristics, such as specific gene mutations.

Learn more >

An illustration of white blood cells attacking a cancer cell.

The Latest in Immunotherapy for Pediatric Solid Tumors Combining immunotherapy agents is showing promise against pediatric solid tumors

Learn more >

Advancements in Immunology and Precision Cancer Medicine Dana-Farber is advancing immunotherapy and paving the way to individual precision cancer treatment.

Learn more >

From trial to treatment, our discoveries in immunotherapy are now saving lives.

Helping Barry’s Body Beat Cancer with Immunotherapy Given less than 6 months to live in 2013, Barry is now thriving thanks to immunotherapy.

Learn more >

Immunotherapy Keeps Stage IV Lung Cancer Patient in Remission When Robert was out of treatment options for stage IV lung cancer, immunotherapy put him in remission.

Learn more >

While Enjoying College, Ewing Sarcoma Survivor Looks to Her Past An immunotherapy clinical trial has enabled Maddie, a Ewing sarcoma survivor, to enjoy college life.

Learn more >

Kidney Cancer Patient is Living Proof of Nobel Prize Research Shaun beats the odds of stage 4 renal cell carcinoma with a new class of cancer treatment therapy.

Watch now >

Your Gift Helps Save Lives.

Your gift to Dana-Farber supports our lifesaving mission. From our Nobel Prize winning research, to our advancements in immunotherapy and successful clinical trials, your support helps us make great strides in the fight against cancer. Every gift helps advance our progress toward a cancer-free future.

Give to Dana-Farber